Inspire Medical Systems, Inc. INSP
70.50
1.69
2.46%
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 15.1×
Follow INSP
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
6.54% | 19.77% | 18.37% | 17.96% | |
| 5.56% | 16.95% | 15.97% | 15.63% | ||
ROIC |
6.68% | 6.73% | 6.31% | 6.70% | |
Return on Tangible Assets |
7.86% | 24.84% | 22.68% | 21.04% | |
Average Days of Receivables |
44.66 | 47.90 | 41.91 | 41.97 | |
Free Cash Flow per Share |
3.37 | 2.67 | 3.37 | 4.06 | |
Free Cash Flow |
98.82 | 78.48 | 96.71 | 117.09 | |
Capital Expenditures |
(34.87) | (38.50) | (39.82) | (39.98) | |
Piotroski F-Score |
6.00 | 4.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
13.52% | 10.74% | 12.69% | 13.70% | |
Accounts Receivable Turnover |
8.93 | 8.57 | 9.26 | 7.46 | |
Accounts Payable Turnover |
2.83 | 3.54 | 3.67 | 3.11 | |
Inventory Turnover |
1.27 | 1.18 | 0.98 | 0.85 | |
Average Days of Payables |
162.40 | 100.18 | 117.33 | 79.37 | |
Days of Inventory on Hand |
388.67 | 398.06 | 466.07 | 499.17 | |
Tax Rate |
(0.14) | 1.21 | 1.05 | 0.95 | |
Research and Development Expense of Revenue |
12.30% | 11.31% | 11.06% | 11.09% | |
Selling, General and Administrative Expense of Revenue |
68.45% | 68.49% | 69.11% | 69.02% | |
Share Based Compensation of Revenue |
14.89% | 14.28% | 14.19% | 13.28% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
3.00 | 0.80 | 1.04 | 1.16 | |
Depreciation/Fixed assets |
0.09 | 0.11 | 0.14 | 0.15 | |
Capex/Depreciation |
(4.07) | (3.48) | (2.83) | (2.51) | |
Revenue per Share |
30.09 | 31.05 | 31.89 | 31.17 | |
Operating CF per Share |
4.56 | 3.98 | 4.76 | 5.45 | |
Capex per Share |
(1.19) | (1.31) | (1.39) | (1.39) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
5.05% | 15.95% | 14.33% | 15.03% |
Columns are period end dates